Why is Indrapr.Medical falling/rising?

As of 22-Jul, Indraprastha Medical Corporation Ltd is experiencing a decline in its stock price, currently at 472.25, reflecting a decrease of 3.85 points or 0.81%. The stock has underperformed its sector by 1.55% today and has been on a consecutive downward trend for the last two days, accumulating a total decline of 3.02%. Over the past week, the stock has fallen by 4.79%, while it has shown a significant increase of 17.72% over the past month. Despite its strong long-term performance, with a 97.31% return over the last year and a remarkable 728.51% increase over the past three years, recent investor participation has decreased, as evidenced by a 14.52% drop in delivery volume compared to the five-day average. The company maintains a high return on equity (ROE) of 19.57% and a low debt-to-equity ratio, indicating solid management efficiency and financial health.
In the broader market context, the Sensex has only declined by 0.47% over the past week, suggesting that the stock's short-term performance is lagging behind the benchmark. While the stock has shown impressive long-term growth, with consistent positive results over the last 12 quarters and a healthy operating profit growth rate of 30.21%, the recent price movement indicates a potential correction or profit-taking by investors. The stock is currently trading at a premium compared to its peers, which may also contribute to the recent downward pressure as investors reassess valuations in light of the declining trading volume and short-term performance.